跳至主要内容
临床试验/NCT05526456
NCT05526456已完成不适用

Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

National Cancer Center, China0 个研究点目标入组 207 人开始时间: 2012年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
207
主要终点
LNM rates of the 207 thoracic T1N+ ESCC patients.

研究概览

简要总结

With the deeper tumor invasion, the higher LNM rate beside the bilateral recurrent laryngeal nerves(RLN) was.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
44 Years 至 73 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Our predefined search strategy identified pT1N+ ESCC cases without preoperative treatment, between February 2012 and April 2022.

排除标准

  • The patients were excluded because they were (1)less than 10 lymph nodes removed; (2) lacked specific sites of LNM; or (3) incomplete follow-up information.

结局指标

主要结局

LNM rates of the 207 thoracic T1N+ ESCC patients.

时间窗: 2012.2-2022.4

次要结局

未报告次要终点

研究者

发起方
National Cancer Center, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yin Li

Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

National Cancer Center, China

相似试验

Mapping of Lymph Node Metastasis and Survival For... | 临床试验